SR | Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes

Summary: The article discusses the effectiveness of myo-inositol, a naturally occurring sugar, as a dietary supplement for preventing gestational diabetes in pregnant women. The review included seven randomized controlled trials, with a total of 1319 women who were 10 to 24 weeks pregnant at the start of the studies. The results showed that myo-inositol may reduce the incidence of gestational diabetes, hypertensive disorders of pregnancy, and preterm birth, but there was limited data on other outcomes, such as perinatal mortality and serious infant morbidity. The certainty of the evidence was low to very low due to small sample sizes, inconsistency in doses and timing of administration, and lack of data from diverse populations. The authors suggest that further well-designed studies are needed to assess the effectiveness of myo-inositol in preventing gestational diabetes and improving other health outcomes for mothers and their babies.

Article: Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes – Cochrane Library